作者
Mariella G. Filbin,Itay Tirosh,Volker Hovestadt,McKenzie Shaw,Leah E. Escalante,Nathan D. Mathewson,Cyril Neftel,Nelli Frank,Kristine Pelton,Christine Hebert,Christine Haberler,Keren Yizhak,Johannes Gojo,Kristóf Égervári,Christopher Mount,Peter van Galen,Dennis M. Bonal,Quang‐Dé Nguyen,Alexander Beck,Claire Sinai,Thomas Czech,Christian Dorfer,Liliana Goumnerova,Cinzia Lavarino,Ángel M. Carcaboso,Jaume Mora,Ravindra Mylvaganam,Christina C. Luo,Andreas Peyrl,Mara Popović,Amedeo A. Azizi,Tracy T. Batchelor,Matthew P. Frosch,Maria Martinez‐Lage,Mark W. Kieran,Pratiti Bandopadhayay,Rameen Beroukhim,G. Fritsch,Gad Getz,Orit Rozenblatt–Rosen,Kai W. Wucherpfennig,David N. Louis,Michelle Monje,Irene Slavc,Keith L. Ligon,Todd R. Golub,Aviv Regev,B Bernstein,Mario L. Suvà
摘要
The cellular composition of H3K27M gliomas Diffuse midline gliomas with histone H3 lysine27-to-methionine mutations (H3K27M-glioma) are an aggressive type of childhood cancer with few options for treatment. Filbin et al. used a single-cell sequencing approach to study the oncogenic programs, genetics, and cellular hierarchies of H3K27M-glioma. Tumors were mainly composed of cells resembling oligodendrocyte precursor cells, whereas differentiated malignant cells were a smaller fraction. In comparison with other gliomas, these cancers had distinct oncogenic programs and stem cell–like profiles that contributed to their stable tumor-propagating potential. The analysis also identified a lineage-specific marker that may be useful in developing therapies. Science , this issue p. 331